Lazard Asset Management LLC Morphic Holding, Inc. Transaction History

Lazard Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$26.01 - $48.69 $55,323 - $103,563	-2,127 Reduced 87.1%	315 $11,000
Q3 2022 Nov 14, 2022	BUY	$22.23 - $33.37 $54,285 - $81,489	2,442 New	2,442 $69,000
Q1 2021 May 14, 2021	SELL	$29.77 - $84.85 $58,765 - $167,493	-1,974 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$25.66 - $34.55 $50,652 - $68,201	1,974 New	1,974 $66,000

142

37.9M

13.5K

190K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.